As we highlighted last month, preferred shares of Fannie Mae and Freddie Mac experienced dramatic increases in dollar trading volume to start 2019. That was not the case in February however, as dollar volume in the mortgage liquidity providers receded back to normal levels.
While different share classes of Fannie and Freddie did occupy seven of the top 12 most-active securities on the OTCQB Venture market in February, they all experienced month-over-month declines in dollar trading volume compared to January. Dollar volume in shares of Fannie Mae FNMAS, Fannie Mae FNMA, Freddie Mac FMCKJ, and Freddie Mac FMCC fell an average of 57 percent month-over-month.
This trend continued across many of the largest securities on OTC Markets in February, particularly among large multinationals. Of the most actively traded securities on the OTCQX Best Market (the top tier of OTC Markets), international conglomerates Roche Holding Ltd RHHBY, adidas AG ADDYY, Danone DANOY, and BNP Paribas BNPQY all experienced lower dollar volume in February compared to January.
That’s not to say there are not OTCQX securities that didn’t experience volume increases in the month. Dollar volume in Mexican banking group Grupo Financiero Banorte, S.A.B. De C.V. GBOOY increased 125 percent in February, and Dutch health multinational Royal DSM NV RDSMY rose 109 percent.
Interestingly, the Grayscale Bitcoin Trust (BTC) GBTC and Organigram Holdings, Inc. OGRMF—two securities that represent emerging industries—saw increases of 9 and 56 percent in February, suggesting investors had more of a risk-on appetite during the month.
Similarly, three cannabis companies on the OTCQB Venture Market saw massive dollar volume increases in February. Khiron Life Sciences Corp. KHRNF, Leafbuyer Technologies, Inc. LBUY, and Plus Products Inc. PLPRF saw dollar volume increases of 277 percent, 157 percent, and 810 percent respectively.
Overall, volume was down among most of the larger names on OTCQB. Of the 10 most actively traded securities on the OTCQB Market in February, only NaturalShrimp Incorporated SHMP (up 1,713 percent), Cleanspark, Inc. CLSK (up 916 percent) and one class of Fannie Mae FNMAT (up 165 percent) saw their dollar trading volume increase from January.
Here’s a list of the top 12 most actively traded securities on the OTCQX and OTCQB Markets in February.
OTCQX:
| COMPANY | COUNTRY | JAN. VOLUME | FEB.VOLUME | ||
|---|---|---|---|---|---|
| Roche Holding Ltd RHHBY |
Switzerland | $1,079,606,596 | $911,092,701 | ||
| Grayscale Bitcoin Trust GBTC | U.S. | $161,681,343 | $175,629,021 | ||
| adidas AG ADDYY | Germany | $169,355,902 | $136,490,312 | ||
| Danone DANOY | France | $204,292,004 | $122,847,380 | ||
| Organigram Holdings, Inc. OGRMF | Canada | $74,363,433 | $116,218,207 | ||
| Grupo Financiero Banorte, S.A.B. De C.V. GBOOY | Mexico | $51,073,673 | $114,910,856 | ||
| BNP Paribas BNPQY | France | $146,710,509 | $106,827,223 | ||
| Royal DSM NV RDSMY | The Netherlands | $44,813,473 | $93,439,380 | ||
| AXA AXAHY | France | $161,375,225 | $92,781,899 | ||
| Medmen Enterprises Inc. MMNFF | U.S. | $71,646,472 | $89,078,239 | ||
| BASF SE BASFY | Germany | $222,497,371 | $84,525,424 | ||
| Imperial Brands PLC IMBBY | United Kingdom | $248,207,558 | $83,766,246 |
OTCQB
| COMPANY | COUNTRY | JAN. VOLUME | FEB. VOLUME | ||
|---|---|---|---|---|---|
| Fannie Mae FNMAS | U.S. | $619,571,945 | $296,092,206 | ||
| Fannie Mae FNMA | U.S. | $828,721,292 | $291,190,951 | ||
| Freddie Mac FMCKJ | U.S. | $470,164,203 | $218,477,784 | ||
| NaturalShrimp Incorporated SHMP | U.S. | $11,559,867 | $209,621,992 | ||
| Freddie Mac FMCC | U.S. | $343,034,008 | $138,365,957 | ||
| KushCo Holdings, Inc. KSHB | U.S. | $174,152,341 | $98,619,481 | ||
| CV Sciences, Inc. CVSI | U.S. | $104,212,212 | $68,246,738 | ||
| Cleanspark, Inc. CLSK | U.S. | $6,372,806 | $64,723,666 | ||
| Fannie Mae FNMAT | U.S. | $20,891,849 | $55,267,374 | ||
| Fannie Mae FNMFN | U.S. | $29,382,633 | $47,132,741 | ||
| Khiron Life Sciences Corp. KHRNF | Canada | $9,640,467 | $36,359,699 | ||
| Fannie Mae FMCKM | U.S. | $11,796,584 | $33,308,472 |
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.